原发性醛固酮增多症合并蛋白尿患者左心室的解剖和功能重构。

IF 3.3 3区 医学 Q2 PHARMACOLOGY & PHARMACY Therapeutic Advances in Chronic Disease Pub Date : 2023-01-01 DOI:10.1177/20406223221143253
Ting-Wei Kao, Xue-Ming Wu, Che-Wei Liao, Cheng-Hsuan Tsai, Zheng-Wei Chen, Yi-Yao Chang, Bo-Ching Lee, Yu-Wei Chiu, Tai-Shuan Lai, Vin-Cent Wu, Yen-Hung Lin, Chi-Sheng Hung
{"title":"原发性醛固酮增多症合并蛋白尿患者左心室的解剖和功能重构。","authors":"Ting-Wei Kao,&nbsp;Xue-Ming Wu,&nbsp;Che-Wei Liao,&nbsp;Cheng-Hsuan Tsai,&nbsp;Zheng-Wei Chen,&nbsp;Yi-Yao Chang,&nbsp;Bo-Ching Lee,&nbsp;Yu-Wei Chiu,&nbsp;Tai-Shuan Lai,&nbsp;Vin-Cent Wu,&nbsp;Yen-Hung Lin,&nbsp;Chi-Sheng Hung","doi":"10.1177/20406223221143253","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary aldosteronism (PA) is the leading cause of secondary hypertension globally and is associated with adverse cardiovascular outcomes. However, the cardiac impact of concomitant albuminuria remains unknown.</p><p><strong>Objective: </strong>To compare anatomical and functional remodeling of left ventricle (LV) in PA patients with or without albuminuria.</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Methods: </strong>The cohort was separated into two arms according to the presence or absence of albuminuria (>30 mg/g of morning spot urine). Propensity score matching with age, sex, systolic blood pressure, and diabetes mellitus was performed. Multivariate analysis was conducted with adjustments for age, sex, body mass index, systolic blood pressure, duration of hypertension, smoking, diabetes mellitus, number of antihypertensive agents, and aldosterone level. A local-linear model with bandwidth of 2.07 was used to study correlations.</p><p><strong>Results: </strong>A total of 519 individuals with PA were enrolled in the study, of whom 152 had albuminuria. After matching, the albuminuria group had a higher creatinine level, at baseline. With regard to LV remodeling, albuminuria was independently associated with a significantly higher interventricular septum (1.22 > 1.17 cm, <i>p</i> = 0.030), LV posterior wall thickness (1.16 > 1.10 cm, <i>p</i> = 0.011), LV mass index (125 > 116 g/m<sup>2</sup>, <i>p</i> = 0.023), and medial E/e' ratio (13.61 > 12.30, <i>p</i> = 0.032), and a lower medial early diastolic peak velocity (5.70 < 6.36 cm/s, <i>p</i> = 0.016). Multivariate analysis further revealed that albuminuria was an independent risk factor for elevated LV mass index (<i>p</i> < 0.001) and medial E/e' ratio (<i>p</i> = 0.010). Non-parametric kernel regression also demonstrated that the level of albuminuria was positively correlated with LV mass index. The remodeling of LV mass and diastolic function under the presence of albuminuria distinctly improved after PA treatment.</p><p><strong>Conclusion: </strong>The presence of concomitant albuminuria in patients with PA was associated with pronounced LV hypertrophy and compromised LV diastolic function. These alterations were reversible after treatment for PA.</p><p><strong>Plain language summary: </strong><b>Cardiac Impact of Primary Aldosteronism and Albuminuria</b> Primary aldosteronism and albuminuria has been, respectively, demonstrated to bring about left ventricular remodeling, but the aggregative effect was unknown. We constructed a prospective single-center cohort study in Taiwan. We proposed the presence of concomitant albuminuria was associated with left ventricular hypertrophy and compromised diastolic function. Intriguingly, management of primary aldosteronism was able to restore these alterations. Our study delineated the cardiorenal crosstalk in the setting of secondary hypertension and the role of albuminuria for left ventricular remodeling. Future interrogations toward the underlying pathophysiology as well as therapeutics will facilitate the improvement of holistic care for such population.</p>","PeriodicalId":22960,"journal":{"name":"Therapeutic Advances in Chronic Disease","volume":"14 ","pages":"20406223221143253"},"PeriodicalIF":3.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/a3/10.1177_20406223221143253.PMC9969461.pdf","citationCount":"0","resultStr":"{\"title\":\"Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria.\",\"authors\":\"Ting-Wei Kao,&nbsp;Xue-Ming Wu,&nbsp;Che-Wei Liao,&nbsp;Cheng-Hsuan Tsai,&nbsp;Zheng-Wei Chen,&nbsp;Yi-Yao Chang,&nbsp;Bo-Ching Lee,&nbsp;Yu-Wei Chiu,&nbsp;Tai-Shuan Lai,&nbsp;Vin-Cent Wu,&nbsp;Yen-Hung Lin,&nbsp;Chi-Sheng Hung\",\"doi\":\"10.1177/20406223221143253\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Primary aldosteronism (PA) is the leading cause of secondary hypertension globally and is associated with adverse cardiovascular outcomes. However, the cardiac impact of concomitant albuminuria remains unknown.</p><p><strong>Objective: </strong>To compare anatomical and functional remodeling of left ventricle (LV) in PA patients with or without albuminuria.</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Methods: </strong>The cohort was separated into two arms according to the presence or absence of albuminuria (>30 mg/g of morning spot urine). Propensity score matching with age, sex, systolic blood pressure, and diabetes mellitus was performed. Multivariate analysis was conducted with adjustments for age, sex, body mass index, systolic blood pressure, duration of hypertension, smoking, diabetes mellitus, number of antihypertensive agents, and aldosterone level. A local-linear model with bandwidth of 2.07 was used to study correlations.</p><p><strong>Results: </strong>A total of 519 individuals with PA were enrolled in the study, of whom 152 had albuminuria. After matching, the albuminuria group had a higher creatinine level, at baseline. With regard to LV remodeling, albuminuria was independently associated with a significantly higher interventricular septum (1.22 > 1.17 cm, <i>p</i> = 0.030), LV posterior wall thickness (1.16 > 1.10 cm, <i>p</i> = 0.011), LV mass index (125 > 116 g/m<sup>2</sup>, <i>p</i> = 0.023), and medial E/e' ratio (13.61 > 12.30, <i>p</i> = 0.032), and a lower medial early diastolic peak velocity (5.70 < 6.36 cm/s, <i>p</i> = 0.016). Multivariate analysis further revealed that albuminuria was an independent risk factor for elevated LV mass index (<i>p</i> < 0.001) and medial E/e' ratio (<i>p</i> = 0.010). Non-parametric kernel regression also demonstrated that the level of albuminuria was positively correlated with LV mass index. The remodeling of LV mass and diastolic function under the presence of albuminuria distinctly improved after PA treatment.</p><p><strong>Conclusion: </strong>The presence of concomitant albuminuria in patients with PA was associated with pronounced LV hypertrophy and compromised LV diastolic function. These alterations were reversible after treatment for PA.</p><p><strong>Plain language summary: </strong><b>Cardiac Impact of Primary Aldosteronism and Albuminuria</b> Primary aldosteronism and albuminuria has been, respectively, demonstrated to bring about left ventricular remodeling, but the aggregative effect was unknown. We constructed a prospective single-center cohort study in Taiwan. We proposed the presence of concomitant albuminuria was associated with left ventricular hypertrophy and compromised diastolic function. Intriguingly, management of primary aldosteronism was able to restore these alterations. Our study delineated the cardiorenal crosstalk in the setting of secondary hypertension and the role of albuminuria for left ventricular remodeling. Future interrogations toward the underlying pathophysiology as well as therapeutics will facilitate the improvement of holistic care for such population.</p>\",\"PeriodicalId\":22960,\"journal\":{\"name\":\"Therapeutic Advances in Chronic Disease\",\"volume\":\"14 \",\"pages\":\"20406223221143253\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/a3/10.1177_20406223221143253.PMC9969461.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Chronic Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/20406223221143253\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/20406223221143253","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:原发性醛固酮增多症(PA)是全球继发性高血压的主要原因,并与不良心血管结局相关。然而,合并蛋白尿对心脏的影响尚不清楚。目的:比较合并蛋白尿和不合并蛋白尿的PA患者左心室(LV)的解剖和功能重构。设计:前瞻性队列研究。方法:根据有无蛋白尿(晨斑尿>30 mg/g)分为两组。进行与年龄、性别、收缩压和糖尿病相匹配的倾向评分。调整年龄、性别、体重指数、收缩压、高血压病程、吸烟、糖尿病、降压药数量、醛固酮水平等因素进行多因素分析。采用带宽为2.07的局部线性模型研究相关性。结果:共有519名PA患者参加了这项研究,其中152名患有蛋白尿。匹配后,蛋白尿组的肌酐水平高于基线水平。在左室重构方面,尿白蛋白与室间隔(1.22 > 1.17 cm, p = 0.030)、左室后壁厚度(1.16 > 1.10 cm, p = 0.011)、左室质量指数(125 > 116 g/m2, p = 0.023)、内侧E/ E′比(13.61 > 12.30,p = 0.032)和内侧舒张早期峰值流速(5.70 p = 0.016)显著升高独立相关。多因素分析进一步显示,蛋白尿是左室质量指数升高的独立危险因素(p p = 0.010)。非参数核回归也显示蛋白尿水平与左室质量指数呈正相关。经PA治疗后,蛋白尿存在下左室体积重构及舒张功能明显改善。结论:PA患者伴发蛋白尿与明显的左室肥厚和左室舒张功能受损有关。这些改变在治疗PA后是可逆的。原发性醛固酮增多症和蛋白尿对心脏的影响已分别证明原发性醛固酮增多症和蛋白尿可引起左心室重构,但其聚集作用尚不清楚。我们在台湾建立了一项前瞻性单中心队列研究。我们认为伴随性蛋白尿与左心室肥厚和舒张功能受损有关。有趣的是,原发性醛固酮增多症的治疗能够恢复这些改变。我们的研究描述了继发性高血压的心肾串扰和蛋白尿在左心室重构中的作用。未来对潜在病理生理学和治疗学的研究将有助于改善对这类人群的整体护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria.

Background: Primary aldosteronism (PA) is the leading cause of secondary hypertension globally and is associated with adverse cardiovascular outcomes. However, the cardiac impact of concomitant albuminuria remains unknown.

Objective: To compare anatomical and functional remodeling of left ventricle (LV) in PA patients with or without albuminuria.

Design: Prospective cohort study.

Methods: The cohort was separated into two arms according to the presence or absence of albuminuria (>30 mg/g of morning spot urine). Propensity score matching with age, sex, systolic blood pressure, and diabetes mellitus was performed. Multivariate analysis was conducted with adjustments for age, sex, body mass index, systolic blood pressure, duration of hypertension, smoking, diabetes mellitus, number of antihypertensive agents, and aldosterone level. A local-linear model with bandwidth of 2.07 was used to study correlations.

Results: A total of 519 individuals with PA were enrolled in the study, of whom 152 had albuminuria. After matching, the albuminuria group had a higher creatinine level, at baseline. With regard to LV remodeling, albuminuria was independently associated with a significantly higher interventricular septum (1.22 > 1.17 cm, p = 0.030), LV posterior wall thickness (1.16 > 1.10 cm, p = 0.011), LV mass index (125 > 116 g/m2, p = 0.023), and medial E/e' ratio (13.61 > 12.30, p = 0.032), and a lower medial early diastolic peak velocity (5.70 < 6.36 cm/s, p = 0.016). Multivariate analysis further revealed that albuminuria was an independent risk factor for elevated LV mass index (p < 0.001) and medial E/e' ratio (p = 0.010). Non-parametric kernel regression also demonstrated that the level of albuminuria was positively correlated with LV mass index. The remodeling of LV mass and diastolic function under the presence of albuminuria distinctly improved after PA treatment.

Conclusion: The presence of concomitant albuminuria in patients with PA was associated with pronounced LV hypertrophy and compromised LV diastolic function. These alterations were reversible after treatment for PA.

Plain language summary: Cardiac Impact of Primary Aldosteronism and Albuminuria Primary aldosteronism and albuminuria has been, respectively, demonstrated to bring about left ventricular remodeling, but the aggregative effect was unknown. We constructed a prospective single-center cohort study in Taiwan. We proposed the presence of concomitant albuminuria was associated with left ventricular hypertrophy and compromised diastolic function. Intriguingly, management of primary aldosteronism was able to restore these alterations. Our study delineated the cardiorenal crosstalk in the setting of secondary hypertension and the role of albuminuria for left ventricular remodeling. Future interrogations toward the underlying pathophysiology as well as therapeutics will facilitate the improvement of holistic care for such population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease Medicine-Medicine (miscellaneous)
CiteScore
6.20
自引率
0.00%
发文量
108
审稿时长
12 weeks
期刊介绍: Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.
期刊最新文献
Synchronized application of closed-loop NMES and precision tACS in post-stroke hand rehabilitation: a protocol of neurorehabilitation trial. Quantitative evaluation of risk factors for low back pain in young patients using synthetic magnetic resonance imaging and proton density fat fraction analyses. Association between serum pyridoxal 5'-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study. The early diagnostic value of serum renalase level in diabetic kidney disease and diabetic macroangiopathy: a retrospective case-control study. Optimal treatment targets for lupus nephritis using per-protocol repeat kidney biopsy findings at 2 years and clinical data up to 5 years: a single-center observational study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1